PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+4.69%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.12B
AUM Growth
+$4.12B
(+12%)
Cap. Flow
+$490M
Cap. Flow
% of AUM
11.9%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
108
New
19
Increased
30
Reduced
27
Closed
22
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$203M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$178M |
| 3 |
Gilead Sciences
GILD
|
$92.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
$83.1M |
| 5 |
Alibaba
BABA
|
$65.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$95.3M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$83.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$77.2M |
| 4 |
Pfizer
PFE
|
$52M |
| 5 |
Elevance Health
ELV
|
$44.4M |
Sector Composition
| 1 | Healthcare | 70.69% |
| 2 | Technology | 11.2% |
| 3 | Communication Services | 5.11% |
| 4 | Consumer Discretionary | 4.12% |
| 5 | Financials | 2.79% |
